| Ref ID | 459 |
| First Author | M. Roseman |
| Journal | BMJ |
| Year Of Publishing | 2012 |
| URL | https://www.bmj.com/content/bmj/345/bmj.e5155.full.pdf |
| Keywords |
• Transparency • Cochrane • Allegiance • Pharmacological • Disclosure |
| Problem(s) |
• Funding or sponsor of systematic review not reported • Conflicts of interest or funding of included studies not assessed |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | Canada |
| Aim | To assess the degree to which Cochrane reviews of drug interventions published in 2010 reported conflicts of interest or funding from included trials. |
| Level of Investigation | Descriptive |
| Summary of Findings | 30% of included reviews reported information on the funding sources of included trials, including 20% that reported information on trial funding for all included trials and 11% that reported for some, but not all, trials. Only 11% provided any information on trial author-industry financial ties or trial author-industry employment. Information on trial funding and trial author-industry ties was reported in one to seven locations within each review, with no consistent reporting location observed. |
| Number of systematic reviews included | 151 |
| Number of eligible systematic reviews assessed | 272 |
| Treatment impacted | No |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |